Hematopoietic stem cell transplantation is a procedure necessitating the administration of
high-dose chemoradiotherapy. This therapy may induce aggressive disruptions that can lead …

… Raquel de Paz … We thank Kevin Liu and Helgi Van de Velde for their statistical support and
fruitful discussion; and Stephen Hill for providing editorial support, editing, and reviewing for …

Purpose To perform a critical analysis on the impact of depth of response in newly diagnosed
multiple myeloma (MM). Patients and Methods Data were analyzed from 609 patients who …

Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized
by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers …

The achievement of complete response (CR) after high-dose therapy/autologous stem cell
transplantation (HDT/ASCT) is a surrogate for prolonged survival in multiple myeloma; …

… Patients were treated according to the GEM0565y PETHEMA/GEM (Programa para el
Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma) trial.In brief …

Background Transcranial direct-current stimulation (tDCS) is an easy-to-apply, cheap, and
safe technique capable of affecting cortical brain activity. However, its effectiveness has not …

… Raphael De Paz2, … et test clinique de dénomination contrôlée: effet relatif de 7 variables
expérimentales sur les performances de 16 sujets atteints de maladies dégénératives. Rev …

Background: Treatment-free remission (TFR)—that is, stopping tyrosine kinase inhibitor (TKI)
therapy without loss of response—is an emerging treatment goal in chronic myeloid …

… in WHO-based Prognostic Scoring System [WPSS]) and iron overload (defined as serum
ferritin level >1,000 ng/mL) in a large series of 2,994 patients (median age, 74 yr) with de novo …